184 related articles for article (PubMed ID: 1334690)
1. Clinical trials referral resource. High priority trials--III. Breast cancer.
Cheson BD; Ungerleider RS
Oncology (Williston Park); 1992 Dec; 6(12):46-50. PubMed ID: 1334690
[No Abstract] [Full Text] [Related]
2. Clinical trials referral resource. Adjuvant therapy of breast cancer.
Cheson BD
Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
[No Abstract] [Full Text] [Related]
3. Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B.
Hurd DD; Peters WP
J Natl Cancer Inst Monogr; 1995; (19):41-4. PubMed ID: 7577204
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of in situ ductal cancers of the breast].
Rochet Y
Rev Fr Gynecol Obstet; 1991 Nov; 86(11):666-8. PubMed ID: 1664138
[TBL] [Abstract][Full Text] [Related]
5. [Primary and adjuvant treatment of breast cancer: an update].
Perey L; Leyvraz S
Schweiz Rundsch Med Prax; 1994 Aug; 83(31):852-6. PubMed ID: 8091052
[TBL] [Abstract][Full Text] [Related]
6. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
Sidorova NA; Volchenko NN; Saribekian EK
Sov Med; 1991; (11):15-8. PubMed ID: 1662831
[TBL] [Abstract][Full Text] [Related]
7. [Long-term results of breast-conservation therapy for breast neoplasms].
Ogawa T; Kanauchi H; Tsuji E; Kurabayashi R; Kaminishi M
Nihon Rinsho; 2007 Jun; 65 Suppl 6():422-7. PubMed ID: 17682187
[No Abstract] [Full Text] [Related]
8. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
Ogawa Y; Nishioka A; Inomata T; Hamada N; Terashima M; Yoshida S; Tanaka Y; Ogoshi S; Araki K; Kumon M
Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
[TBL] [Abstract][Full Text] [Related]
9. In situ or localized breast cancer--how much treatment is needed?
Swain SM
N Engl J Med; 1993 Jun; 328(22):1633-4. PubMed ID: 8387638
[No Abstract] [Full Text] [Related]
10. Dealing with DCIS.
Lawrence G
Hosp Pract (Off Ed); 1992 Feb; 27(2A):14-5. PubMed ID: 1310689
[No Abstract] [Full Text] [Related]
11. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
[No Abstract] [Full Text] [Related]
13. Isolated/primary CNS relapse in women in remission after ABMT for metastatic breast cancer.
Ellis ED; Williams SF
Bone Marrow Transplant; 1992 Feb; 9(2):147-9. PubMed ID: 1315184
[No Abstract] [Full Text] [Related]
14. Contemporary treatment of ductal carcinoma in situ of the breast.
Mokbel K
Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma-in-situ.
Wickerham DL
J Clin Oncol; 2001 Sep; 19(18 Suppl):98S-100S. PubMed ID: 11560982
[No Abstract] [Full Text] [Related]
16. [Current trends in the treatment of primary breast cancer].
Letiagin VP
Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
[No Abstract] [Full Text] [Related]
17. Image-detected breast cancer: state of the art diagnosis and treatment.
Silverstein MJ; Lagios MD; Recht A; Allred DC; Harms SE; Holland R; Holmes DR; Hughes LL; Jackman RJ; Julian TB; Kuerer HM; Mabry HC; McCready DR; McMasters KM; Page DL; Parker SH; Pass HA; Pegram M; Rubin E; Stavros AT; Tripathy D; Vicini F; Whitworth PW
J Am Coll Surg; 2005 Oct; 201(4):586-97. PubMed ID: 16183499
[No Abstract] [Full Text] [Related]
18. [Tumor recurrence in the salvaged breast; a second chance?].
Roukema JA; Dolman A; Maat B
Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2593-5. PubMed ID: 2558321
[No Abstract] [Full Text] [Related]
19. Current management of primary breast cancer. Part II: Adjuvant therapy and management of stage III disease and in-situ carcinoma.
Lopez MJ; Andriole DP
Mo Med; 1990 Oct; 87(10):757-62. PubMed ID: 2175383
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H
J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
